Detalhe da pesquisa
1.
Evaluation of the novel therapeutic anti-CCR7 antibody CAP-100 as an add-on therapy in chronic lymphocytic leukemia patients receiving venetoclax.
Hematol Oncol
; 41(5): 869-876, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37545392
2.
Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia and its implication for the activity of CAP-100, a novel therapeutic anti-CCR7 antibody.
Cancer Immunol Immunother
; 71(3): 627-636, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297159
3.
Preclinical activity of anti-CCR7 immunotherapy in patients with high-risk chronic lymphocytic leukemia.
Cancer Immunol Immunother
; 64(6): 665-76, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25724841
4.
Dasatinib-induced spleen contraction leads to transient lymphocytosis.
Blood Adv
; 7(11): 2418-2430, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36583674
5.
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma.
Sci Transl Med
; 15(702): eabo3826, 2023 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37379367
6.
Ibrutinib Does Not Impact CCR7-Mediated Homeostatic Migration in T-Cells from Chronic Lymphocytic Leukemia Patients.
Cancers (Basel)
; 14(11)2022 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35681706
7.
CCR7 in Blood Cancers - Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target.
Front Oncol
; 11: 736758, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34778050
8.
Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target.
Front Immunol
; 12: 662866, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33841445
9.
Targeting cancer homing into the lymph node with a novel anti-CCR7 therapeutic antibody: the paradigm of CLL.
MAbs
; 13(1): 1917484, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33944659
10.
Evaluation of therapeutic targeting of CCR7 in acute graft-versus-host disease.
Bone Marrow Transplant
; 55(10): 1935-1945, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32086495
11.
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia.
Biomark Res
; 8: 54, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33110606
12.
Immediate Effects of Dasatinib on the Migration and Redistribution of Naïve and Memory Lymphocytes Associated With Lymphocytosis in Chronic Myeloid Leukemia Patients.
Front Pharmacol
; 10: 1340, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31824308
13.
The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model.
J Clin Invest
; 128(7): 2802-2818, 2018 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29781813
14.
Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets.
Front Immunol
; 8: 1936, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29387053
15.
Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner.
Clin Cancer Res
; 23(21): 6697-6707, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28821556
16.
Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma.
J Hematol Oncol
; 6: 89, 2013 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24305507
17.
Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
Exp Hematol
; 38(9): 756-64, 764.e1-4, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20488224
18.
Tie-2 is overexpressed by monocytes in autoimmune thyroid disorders and participates in their recruitment to the thyroid gland.
J Clin Endocrinol Metab
; 94(7): 2626-33, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19351722